Gut Microbiota Dysbiosis: Triggers, Consequences, Diagnostic and Therapeutic Options
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61388971%3A_____%2F22%3A00556628" target="_blank" >RIV/61388971:_____/22:00556628 - isvavai.cz</a>
Výsledek na webu
<a href="https://www.mdpi.com/2076-2607/10/3/578" target="_blank" >https://www.mdpi.com/2076-2607/10/3/578</a>
DOI - Digital Object Identifier
—
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Gut Microbiota Dysbiosis: Triggers, Consequences, Diagnostic and Therapeutic Options
Popis výsledku v původním jazyce
The global incidence of numerous immune-mediated, metabolic, neurodegenerative, and psychiatric diseases is steadily increasing. The increased morbidity of human populations makes them more vulnerable to additional burdens, including infectious diseases. For example, the mortality rate of diabetics infected with the original variant of the SARS Co-2 virus was about twice that of the general population. It is becoming increasingly clear that the gut microbiota plays an important role in the development of many, if not all, of these diseases. Many of these diseases, including COVID-19 infection, are associated with alterations in the composition and function of the gut microbiota, i.e., dysbiosis. The focus of this special issue was on all possible triggers of gut microbiota dysbiosis and on exploring ways to restore the gut microbiota, such as nutritional interventions, probiotics, and FMT, to identify disease-associated microbiota signatures, elucidate pathogenetic mechanisms, find new diagnostic and prognostic markers, and develop new microbiota-based treatments
Název v anglickém jazyce
Gut Microbiota Dysbiosis: Triggers, Consequences, Diagnostic and Therapeutic Options
Popis výsledku anglicky
The global incidence of numerous immune-mediated, metabolic, neurodegenerative, and psychiatric diseases is steadily increasing. The increased morbidity of human populations makes them more vulnerable to additional burdens, including infectious diseases. For example, the mortality rate of diabetics infected with the original variant of the SARS Co-2 virus was about twice that of the general population. It is becoming increasingly clear that the gut microbiota plays an important role in the development of many, if not all, of these diseases. Many of these diseases, including COVID-19 infection, are associated with alterations in the composition and function of the gut microbiota, i.e., dysbiosis. The focus of this special issue was on all possible triggers of gut microbiota dysbiosis and on exploring ways to restore the gut microbiota, such as nutritional interventions, probiotics, and FMT, to identify disease-associated microbiota signatures, elucidate pathogenetic mechanisms, find new diagnostic and prognostic markers, and develop new microbiota-based treatments
Klasifikace
Druh
O - Ostatní výsledky
CEP obor
—
OECD FORD obor
10606 - Microbiology
Návaznosti výsledku
Projekt
Výsledek vznikl pri realizaci vícero projektů. Více informací v záložce Projekty.
Návaznosti
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2022
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů